Hepatitis Monthly

Published by: Kowsar

Association Between TT Virus Infection and Cirrhosis in Liver Transplant Patients

Mohammad Javad Kazemi 1 , Ramin Yaghobi 2 , * , Mahdiyar Iravani Saadi 2 , Bita Geramizadeh 2 and Javad Moayedi 2
Authors Information
1 Department of Biology, Ashkezar Branch, Islamic Azad University, Ashkezar, Yazd, IR Iran
2 Shiraz Transplant Research Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Hepatitis Monthly: September 01, 2015, 15 (9); e28370
  • Published Online: September 27, 2015
  • Article Type: Research Article
  • Received: March 3, 2015
  • Revised: May 23, 2015
  • Accepted: August 19, 2015
  • DOI: 10.5812/hepatmon.28370

To Cite: Kazemi M J, Yaghobi R, Iravani Saadi M, Geramizadeh B, Moayedi J. et al. Association Between TT Virus Infection and Cirrhosis in Liver Transplant Patients, Hepat Mon. 2015 ; 15(9):e28370. doi: 10.5812/hepatmon.28370.

Abstract
Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Biagini P. Classification of TTV and related viruses (anelloviruses). Curr Top Microbiol Immunol. 2009; 331: 21-33[PubMed]
  • 2. Okamoto H, Takahashi M, Nishizawa T, Tawara A, Sugai Y, Sai T, et al. Replicative forms of TT virus DNA in bone marrow cells. Biochem Biophys Res Commun. 2000; 270(2): 657-62[DOI][PubMed]
  • 3. Hino S, Miyata H. Torque teno virus (TTV): current status Rev Med Virol. 2007; 17(1): 45-57
  • 4. Okamoto H. History of discoveries and pathogenicity of TT viruses. Curr Top Microbiol Immunol. 2009; 331: 1-20[PubMed]
  • 5. Zheng MY, Lin Y, Li DJ, Ruan HB, Chen Y, Wu TT. [TTV and HPV co-infection in cervical smears of patients with cervical lesions in littoral of Zhejiang province]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010; 24(2): 110-2[PubMed]
  • 6. Maeda M, Hamada H, Tsuda A, Kaneko K, Fukunaga Y. High rate of TTV infection in multitransfused patients with pediatric malignancy and hematological disorders. Am J Hematol. 2000; 65(1): 41-4[PubMed]
  • 7. Maggi F, Pistello M, Vatteroni M, Presciuttini S, Marchi S, Isola P, et al. Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection. J Virol. 2001; 75(24): 11999-2004[DOI][PubMed]
  • 8. Zhong S, Yeo W, Tang M, Liu C, Lin XR, Ho WM, et al. Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients. J Med Virol. 2002; 66(3): 428-34[PubMed]
  • 9. Suzuki F, Chayama K, Tsubota A, Akuta N, Someya T, Kobayashi M, et al. Pathogenic significance and organic virus levels in patients infected with TT virus. Intervirology. 2001; 44(5): 291-7[PubMed]
  • 10. Hu ZJ, Lang ZW, Zhou YS, Yan HP, Huang DZ, Chen WR, et al. Clinicopathological study on TTV infection in hepatitis of unknown etiology. World J Gastroenterol. 2002; 8(2): 288-93[PubMed]
  • 11. Bendinelli M, Pistello M, Maggi F, Fornai C, Freer G, Vatteroni ML. Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clin Microbiol Rev. 2001; 14(1): 98-113[DOI][PubMed]
  • 12. Moriyama M, Matsumura H, Shimizu T, Shioda A, Kaneko M, Miyazawa K, et al. Histopathologic impact of TT virus infection on the liver of type C chronic hepatitis and liver cirrhosis in Japan. J Med Virol. 2001; 64(1): 74-81[PubMed]
  • 13. Camci C, Guney C, Balkan A, Buyukberber N, Buyukberber S, Kadayifci A, et al. The prevalence of TT virus in cancer patients. New Microbiol. 2002; 25(4): 463-8[PubMed]
  • 14. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology. 1993; 104(6): 1755-61[PubMed]
  • 15. Baeres M, Herkel J, Czaja AJ, Wies I, Kanzler S, Cancado EL, et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut. 2002; 51(2): 259-64[PubMed]
  • 16. Czaja AJ, Donaldson PT, Lohse AW. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol. 2002; 97(2): 413-9[DOI][PubMed]
  • 17. Czaja AJ, Pfeifer KD, Decker RH, Vallari AS. Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci. 1996; 41(9): 1733-40[PubMed]
  • 18. Battle WM, Matarazzo SA, Selhat GF, Catalano E. Alpha-1-antitrypsin deficiency--a cause of cryptogenic liver disease in the elderly. J Clin Gastroenterol. 1982; 4(3): 269-73[PubMed]
  • 19. Marmur J, Bergquist A, Stal P. Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome. Scand J Gastroenterol. 2010; 45(1): 60-9[DOI][PubMed]
  • 20. Nayak NC, Vasdev N, Saigal S, Soin AS. End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol. 2010; 41(3): 425-30[DOI][PubMed]
  • 21. Duclos-Vallee JC, Yilmaz F, Johanet C, Roque-Afonso AM, Gigou M, Trichet C, et al. Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clin Transplant. 2005; 19(5): 591-9[DOI][PubMed]
  • 22. Greeve M, Ferrell L, Kim M, Combs C, Roberts J, Ascher N, et al. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology. 1993; 17(4): 593-8[PubMed]
  • 23. Irshad M, Mandal K, Singh S, Agarwal SK. Torque teno virus infection in hemodialysis patients in North India. Int Urol Nephrol. 2010; 42(4): 1077-83[DOI][PubMed]
  • 24. Charlton MR, Kondo M, Roberts SK, Steers JL, Krom RA, Wiesner RH. Liver transplantation for cryptogenic cirrhosis. Liver Transpl Surg. 1997; 3(4): 359-64[PubMed]
  • 25. Piaggio F, Dodi F, Bottino G, Andorno E, Gentile R, Ferrari C, et al. Torque Teno Virus--cause of viral liver disease following liver transplantation: a case report. Transplant Proc. 2009; 41(4): 1378-9[DOI][PubMed]
  • 26. Tsuge M, Noguchi C, Akiyama R, Matsushita M, Kunihiro K, Tanaka S, et al. G to A hypermutation of TT virus. Virus Res. 2010; 149(2): 211-6[DOI][PubMed]
  • 27. Asim M, Singla R, Gupta RK, Kar P. Clinical & molecular characterization of human TT virus in different liver diseases. Indian J Med Res. 2010; 131: 545-54[PubMed]
  • 28. Akiba J, Umemura T, Alter HJ, Kojiro M, Tabor E. SEN virus: epidemiology and characteristics of a transfusion-transmitted virus. Transfusion. 2005; 45(7): 1084-8[DOI][PubMed]
  • 29. Omar M, El-Din SS, Fam N, Diab M, Shemis M, Raafat M, et al. SEN virus infection in Egyptian patients with chronic hepatitis C and patients undergoing hemodialysis. Medscape J Med. 2008; 10(12): 290[PubMed]
  • 30. Loutfy SA, Hafez MM, Massoud WA, Fotuh NA, Moneer MM, Zaghloul HS. SEN virus infection in Egyptian patients undergoing maintenance hemodialysis: prevalence and clinical importance. J Microbiol Immunol Infect. 2009; 42(6): 464-70[PubMed]
  • 31. Karimi-Rastehkenari A, Bouzari M. High frequency of SEN virus infection in thalassemic patients and healthy blood donors in Iran. Virol J. 2010; 7: 1[DOI][PubMed]
  • 32. Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, et al. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology. 1998; 28(3): 839-42[DOI][PubMed]
  • 33. Czaja AJ. Cryptogenic chronic hepatitis and its changing guise in adults. Dig Dis Sci. 2011; 56(12): 3421-38[DOI][PubMed]
  • 34. Bagheri K, Yaghobi R, Karimi MH, Mohammadi B, Ramzi M. Study the prevalence of torque teno (TT) virus infectionin patients with hematological malignancies. AJMR . 2012; 6(31): 6081-5
  • 35. Hejr S, Karimi MH, Yaghobi R, Kamali-Sarvestani E, Geramizadeh B, Roozbeh J. Association of IL-17, IL-21, and IL-23R gene polymorphisms with HBV infection in kidney transplant patients. Viral Immunol. 2013; 26(3): 201-6[DOI][PubMed]
  • 36. Gimenez-Barcons M, Forns X, Ampurdanes S, Guilera M, Soler M, Soguero C, et al. Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases. J Hepatol. 1999; 30(6): 1028-34[PubMed]
  • 37. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, et al. Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol. 2000; 31(4): 302-8[PubMed]
  • 38. Tokita H, Murai S, Kamitsukasa H, Yagura M, Harada H, Takahashi M, et al. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. J Med Virol. 2002; 67(4): 501-9[DOI][PubMed]
  • 39. Mirzaee M, Yaghobi R, Ramzi M, Roshan Nia M. The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies. Mol Biol Rep. 2012; 39(2): 1217-23[DOI][PubMed]
  • 40. Okamoto H. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res. 1998; 10(1): 1-16[DOI]
  • 41. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun. 1997; 241(1): 92-7[DOI][PubMed]
  • 42. Fujiwara T, Iwata A, Iizuka H, Tanaka T, Okamoto H. Transfusion transmitted virus. Lancet. 1998; 352(9136): 1310-1[DOI][PubMed]
  • 43. Chen BP, Rumi MG, Colombo M, Lin YH, Ramaswamy L, Luna J, et al. TT virus is present in a high frequency of Italian hemophilic patients transfused with plasma-derived clotting factor concentrates. Blood. 1999; 94(12): 4333-6[PubMed]
  • 44. Ergunay K, Gurakan F, Usta Y, Yuce A, Karabulut HO, Ustacelebi S. Detection of TT virus (TTV) by three frequently-used PCR methods targeting different regions of viral genome in children with cryptogenic hepatitis, chronic B hepatitis and hbs carriers. Turk J Pediatr. 2008; 50(5): 432-7[PubMed]
  • 45. Hsieh SY, Wu YH, Ho YP, Tsao KC, Yeh CT, Liaw YF. High prevalence of TT virus infection in healthy children and adults and in patients with liver disease in Taiwan. J Clin Microbiol. 1999; 37(6): 1829-31[PubMed]
  • 46. Leary TP, Erker JC, Chalmers ML, Desai SM, Mushahwar IK. Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals. J Gen Virol. 1999; 80 ( Pt 8): 2115-20[DOI][PubMed]
  • 47. Savas MC, Guney C, Kadayifci A, Balkan A, Koruk M, Kubar A, et al. High prevalence of transfusion-transmitted virus infection in patients with chronic liver diseases in an endemic area of hepatitis B and C virus. Med Princ Pract. 2003; 12(3): 176-9[PubMed]
  • 48. Verdi H. Comparision of two different primer sets for PCR detection of transfusion transmitted virus DNA in blood donors, hemodialysis patients and patients with thalassemia major, chronic HBV and HCV infection. J Hepatol. 2001; 34: 163[DOI]
  • 49. Yamamoto T, Kajino K, Ogawa M, Gotoh I, Matsuoka S, Suzuki K, et al. Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration. Biochem Biophys Res Commun. 1998; 251(1): 339-43[DOI][PubMed]
  • 50. Abraham P, John GT, Raghuraman S, Radhakrishnan S, Thomas PP, Jacob CK, et al. GB virus C/hepatitis G virus and TT virus infections among high risk renal transplant recipients in India. J Clin Virol. 2003; 28(1): 59-69[PubMed]
  • 51. Fiordalisi G, Zanella I, Mantero G, Bettinardi A, Stellini R, Paraninfo G, et al. High prevalence of GB virus C infection in a group of Italian patients with hepatitis of unknown etiology. J Infect Dis. 1996; 174(1): 181-3[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments